Abstract: Disclosed is an injection device for injecting a hypodermic syringe along an injection direction defining an injection axis. The injection device comprises a housing for being positioned at a user's skin, and a movable element movably arranged relative to the housing between a retracted position and an injection position.

Abstract: A system and a method for creating prosthetics using a prosthetic machine are disclosed. The method includes creating a three dimensional (3D) shape of a prosthetic using a software. Successively, the 3D shape is sent for printing based at least on an availability of a printer. The printing is achieved by taking the 3D shape and slicing into very thin horizontal slices and thereafter placing a slice upon a slice for the 3D shape. Further, granular polycarbonate material is placed in a cartridge at the top of a compression head. Further, granules are fed through a four stage heating and compression process. Further, a heated plastic is pressurized and forced through an extruder to extrude in a 1 mm×4 mm ribbon. Thereafter, a printed object is formed on a base plate through motion that is controlled by a plurality of linear axes and a rotary axis.

Abstract: Provided is a method for treating non-alcoholic steatohepatitis (NASH), the method includes administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition and the pharmaceutical composition contains polaprezinc as zinc preparation and sodium selenite as selenium preparation.

Abstract: An injection device adapted for injecting a durable or pre-filled pen device along an injection direction defining an injection axis. The injection device is provided with a certain holder and locking mechanism for fixing and holding a pen device in a correct position for injection into human skin.

Abstract: Provided is a method for treating non-alcoholic steatohepatitis (NASH), the method includes administering to a subject in need thereof a therapeutically effective amount of a pharmaceutical composition and the pharmaceutical composition contains polaprezinc as zinc preparation and sodium selenite as selenium preparation.

Abstract: The present invention relates to metabolic biomarker sets for assessing HIV. In preferred embodiments, the present invention relates to the use of biomarker sets for screening and/or diagnosing HIV infection, for prediction of immunologic response of a mammalian subject to antiretroviral therapy and/or prognosis of HIV disease progression, and for monitoring of HIV disease activity in a mammalian subject. In other embodiments, the invention relates to methods for screening and/or diagnosing HIV infection, for prediction of immunologic response of a mammalian subject to antiretroviral therapy and/or prognosis of HIV disease progression, and for monitoring of HIV disease activity in a mammalian subject, as well as to a kit adapted to carry out the methods. By employing the specific biomarkers and the method according to the present invention it becomes possible to more properly and reliably assess HIV.

Abstract: Disclosed is an injection device (1280) for injecting a hypodermic syringe (1260) along an injection direction defining an injection axis. The injecting device comprises a housing (1281) for being positioned at the skin and a movable element (1282) movably arranged relative to the housing between a retracted position and an injection position. The movable element comprises a hypodermic syringe holder (1289) for holding a hypodermic syringe. Disclosed is further a protective cover (1200) for a needle, and methods for arranging a hypodermic syringe in an injection device.

Abstract: Acidic oral compositions having calcium contents and effective pH-values in the area indicated by grey-tone in FIG. 2 are non-erosive in saliva and capable of stimulating saliva production, even in “dry mouth” patients. A new multi-step test method for determining erosive potential in saliva has been used for identifying the compositions.

Abstract: One describes a system for detecting the physical contact events in a hospital environment (4,4?), wherein the system comprises: at least one transmitting and receiving device (2,2?) associated to a user (3,3?) of the hospital environment (4,4?), a plurality of identifying devices (5) associated to a plurality of articles (6, 7, 8, 9, 10) arranged in the hospital environment (4,4?). The system for detecting the physical contact events in a hospital environment is configured to generate a cleaning signal (90) if the user (3,3?) of the hospital environment (4,4?) establishes physical contact with at least one of the articles (6, 7, 8, 9, 10) arranged in the hospital environment (4,4?). Additionally, the cleaning signal (90) is generated if physical contact is established between different users (3,3?) of the hospital environment (4,4?). One further approaches a method of detecting physical contact events in a hospital environment.

Abstract: One describes a system (1) for monitoring hand-cleaning practices in a hospital environment, the system (1) comprising a set of sensors (2, 3, 4, 5) configured as at least one from: at least one infrared sensor (2) establishing a heat detection zone (20), at least one from a contact sensor (3) and a movement sensor (4) associated to at least one article (10, 10?, 10?) of the hospital environment, at least one actuation sensor (5) of an aseptic substance dispenser (6), the set of sensors (2, 3, 4, 5) being configured to generate a plurality of cleaning signals (11, 11?), the cleaning signals (11, 11?) being associated to a hand-cleaning event, the system further comprising a wearable device (15) to be worn by a user of the system, the wearable device (15) being configured to generate a virtual environment (16) visible to the user, a plurality of indicators (26, 27, 28, 45) related to the cleaning signals (11, 11?) being displayed in the virtual environment (16).

Abstract: The present invention discloses a system of monitoring patients in hospital beds, the system comprising: at least one image capture element (2) disposed in a hospital bed (10) and configured to generate an image parameter (11) of a patient (12) disposed in the hospital bed (10). The system further comprises at least one processor, configured to generate a temperature map (13) of the patient (12) from the image parameter (11). Also disclosed is a method (40) of monitoring patients in hospital beds.

Abstract: Problem to be Solved To provide medicine and health food suitable for treatment and prevention for non-alcoholic fatty liver disease (NAFLAD) and/or non-alcoholic steatohepatitis (NASH) which are not involved with hepatic virus, and/or hepatic fatty degeneration. Means for solving the problem A combination drug suitable for treatment of non-alcoholic fatty liver disease (NAFLAD) and/or non-alcoholic steatohepatitis (NASH), and/or hepatic fatty degeneration, wherein the active ingredients are zinc preparation and selenium preparation.

Abstract: Disclosed is an injection device for injecting a hypodermic syringe along an injection direction defining an injection axis. The injection device comprises a housing for being positioned at a user's skin, and a movable element movably arranged relative to the housing between a retracted position and an injection position.

Abstract: Disclosed is a monitoring system of physical contact events in a hospital environment), wherein the hospital environment comprises at least one operable device by a passer-by in the hospital environment, the system comprising: at least one touch sensor associated with a surface of the operable device, the touch sensor configured in order to identify the occurrence of a physical contact on the surface of the operable device. A method of monitoring physical contact events in a hospital environment is also disclosed.

Abstract: The present invention relates to metabolic biomarker sets for assessing HIV. In preferred embodiments, the present invention relates to the use of biomarker sets for screening and/or diagnosing HIV infection, for prediction of immunologic response of a mammalian subject to antiretroviral therapy and/or prognosis of HIV disease progression, and for monitoring of HIV disease activity in a mammalian subject. In other embodiments, the invention relates to methods for screening and/or diagnosing HIV infection, for prediction of immunologic response of a mammalian subject to antiretroviral therapy and/or prognosis of HIV disease progression, and for monitoring of HIV disease activity in a mammalian subject, as well as to a kit adapted to carry out the methods. By employing the specific biomarkers and the method according to the present invention it becomes possible to more properly and reliably assess HIV.

Abstract: A system comprising for communication medical data includes a patient data component, a provider component, a session component, an authorization component, and a communication component. The patient data component is configured to store patient medical data corresponding to one or more patients. The provider component is configured to store destination information corresponding to a plurality of health care providers that can receive the patient medical data from the system. The session component is configured to establish and validate communication with a first patient via a remote device. The authorization component is configured to receive, from the remote device, a message indicating authorization from the first patient to send the medical data for the first patient to a first health care provider. The communication component is configured to send the medical data for the first patient to the destination information corresponding to the first health care provider.

Abstract: A mobile computing device includes an authentication component, a destination component, a permission component, and a message component. The authentication component is configured to authenticate a user with an authentication server by providing authentication information to the authentication server. The destination component is configured to identify a health care provider available to provide health care for the user and to receive medical data. The permission component is configured to, in response to authenticating the user, receive input from a user indicating authorization to send medical data for the first patient to the health care provider. The message component is configured to send a message providing permission to a remote server to send medical data for the user stored in remote storage to the health care provider.